NewsEvents

Your Yourlocation: Home > Efficacy of tiotropium bromide(136310-93-5) combined with budesonide /formoterol powder in severe and severe COPD stable period

OBJECTIVE: To observe the clinical effect of tiotropium bromide(136310-93-5) combined with budesonide /formoterol inhalation in the treatment of patients with severe severe and severe chronic obstructive pulmonary disease (COPD).

Methods: The clinical data of 48 patients with severe COPD from February 2013 to February 2014 were randomly divided into observation group and control group. The treatment group was treated with tiotropium bromide combined with budesonide /formoterol inhalation and the therapeutic effect of the two groups was observed.

Results: After 4 weeks of continuous treatment, the total effective rate was 85.5% in the observation group and 69.1% in the control group, the difference was statistically significant (P <0.05).

Conclusion: The combination of tiotropium bromide(136310-93-5) combined with budesonide /formoterol inhalation treatment on the basis of conventional therapy is effective in the treatment of severe and severe COPD, which is worthy of clinical application.

Address: TEL:0531-82375879 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved